PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: bitop AG

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

bitop to Exhibit At the in-cosmetics - At this year's in-cosmetics show, taking place on April 1-3 in Hamburg, Germany, the cosmetics department of the extremolyte specialist bitop will showcase for the first time its product portfolio at booth 1K50 - in-cosmetics.com / bitop.de
bitop to Exhibit At the in-cosmetics

 

NewswireToday - /newswire/ - Hamburg, Germany, 2014/03/31 - At this year's in-cosmetics show, taking place on April 1-3 in Hamburg, Germany, the cosmetics department of the extremolyte specialist bitop will showcase for the first time its product portfolio at booth 1K50 - in-cosmetics.com / bitop.de.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Focus of the exhibition at the in-cosmetics is the presentation of bitop's broad extremolyte product portfolio - including the well-known Ectoin® - but also of new ingredients with innovative properties.

Innovative ingredients that fulfil customer demands
New and innovative ingredients for cosmetic products are few and far between. Such that fulfil the demands of end-consumers can almost not be found. With its extremolyte portfolio bitop serves the demands of both sides: the cosmetics manufacturers and end-consumer. bitop's products combine innovation with efficacy and high tolerability.

Glycoin® natural - the cell energizer
Glycoin® natural is biocatalytically processed glyceryl glucoside dissolved in water. Glycoin® natural revitalizes cells and reactivates cell metabolism. Thus, cell viability is stimulated and cell regeneration is accelerated. These properties result in an improvement of the skin functions and regeneration of the skin. Moreover, Glycoin® natural increases the occurrence of natural antioxidants as e.g. superoxide dismutase (SOD) and strengthens the natural self-defense system of the skin. Glycoin® natural calms irritated skin and reduces redness.

28Extremoin® - the anti-pollution agent
Creams for treatment of pigment spots caused by sun exposure are available on the market since years. Products that can help to avoid skin aging caused by air pollutants such as particulate matter or cigarette smoke can hardly be found. 28Extremoin® is one of the first active cosmetic ingredients that protects the skin against damage due to air pollution and their visible results such as hyperpigmentation, wrinkle formation or irritation of the skin. 28Extremoin® reduces significantly the expression of genes such as MMP-1 und POMC that are stimulated by particulate matter.

Ectoin® - the ultimative active
Ectoin® is an established cosmetic active ingredient with excellent properties in the fields of anti-aging and cell protection. It supports the optical rejuvenation of the skin by reducing wrinkles, increasing the skin elasticity, and replenishing moisture that was lost over the time. Moreover, Ectoin® stabilizes the skin barrier and protects skin cells against external influences such as UV-A and UV-B radiation or visible light and combats premature skin ageing. Ectoin® strengthens the skin's own immune system, soothes and smoothes the skin.

High tolerability
All products of bitop's portfolio have a very good safety profile. The modes of action are well understood and their properties were supported by a remarkably broad and deep documentation. All active cosmetic ingredients are suited for sensitive or allergic skin. Their use is explicitly proposed by leading skin specialists.

About bitop AG
bitop AG (bitop.de), a German company founded in 1993, is worldwide recognized as a specialist for biotechnological production of Extremolytes, used in medical devices and as active cosmetic ingredients for personal care products.

Extremolytes are small molecules that are accumulated inside of extremophiles, i.e. microorganisms that thrive under extreme environmental conditions. These small protective molecules create large effects: they stabilize and maintain biological structures and protect the extremophiles from environmental stresses such as variations in temperature, high salt concentrations, strong UV radiation, or dehydration. These characteristics have been made available for human use by bitop, utilizing a highly specialized manufacturing process.

bitop's product portfolio of active cosmetic ingredients comprises besides Ectoin® and Hydroxyectoin further Extremolyte-containing products as Glycoin® natural and 28Extremoin®.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: bitop AG

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


bitop to Exhibit At the in-cosmetics

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Press Office - bitop.de 
+49 2302 91440 0 info[.]bitop.de
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any bitop AG securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From bitop AG / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)